Cell Impact AB Net Assets

Latest as of September 2025: Skr187.48 Million SEK ≈ $20.18 Million USD

Cell Impact AB net assets. Based on the latest financial reports, Cell Impact AB (CI) has net assets worth Skr187.48 Million SEK (≈ $20.18 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr216.69 Million ≈ $23.32 Million USD) and total liabilities (Skr29.21 Million ≈ $3.14 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore CI net assets growth trend to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr187.48 Million
% of Total Assets	86.52%
Annual Growth Rate	48.89%
5-Year Change	8.52%
10-Year Change	9263.88%
Growth Volatility	445.55

Net Assets of Cell Impact AB (2008–2024)

Net assets of Cell Impact AB from 2008 to 2024. This chart illustrates how Cell Impact AB's net assets have evolved over time, based on quarterly financial data. See CI equity to assets ratio to measure how much of total assets are equity-financed.

Annual Net Assets for Cell Impact AB (2008–2024)

The table below shows the annual net assets of Cell Impact AB from 2008 to 2024. For live market cap and overall valuation, see CI market cap overview.

Year	Net Assets	Change
2024-12-31	Skr219.08 Million ≈ $23.58 Million	-27.78%
2023-12-31	Skr303.37 Million ≈ $32.65 Million	-6.47%
2022-12-31	Skr324.35 Million ≈ $34.90 Million	+127.41%
2021-12-31	Skr142.62 Million ≈ $15.35 Million	-29.35%
2020-12-31	Skr201.89 Million ≈ $21.73 Million	+348.11%
2019-12-31	Skr45.05 Million ≈ $4.85 Million	+135.41%
2018-12-31	Skr19.14 Million ≈ $2.06 Million	-17.11%
2017-12-31	Skr23.09 Million ≈ $2.48 Million	-44.20%
2016-12-31	Skr41.38 Million ≈ $4.45 Million	+1668.66%
2015-12-31	Skr2.34 Million ≈ $251.78K	-71.54%
2014-12-31	Skr8.22 Million ≈ $884.78K	-48.88%
2013-12-31	Skr16.08 Million ≈ $1.73 Million	+855.61%
2012-12-31	Skr1.68 Million ≈ $181.13K	-13.11%
2011-12-31	Skr1.94 Million ≈ $208.45K	+409.74%
2010-12-31	Skr380.00K ≈ $40.89K	+1.25%
2009-12-31	Skr375.31K ≈ $40.39K	-0.03%
2008-12-31	Skr375.44K ≈ $40.40K	--

Equity Component Analysis

This analysis shows how different components contribute to Cell Impact AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 59623944000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Cell Impact AB Net Assets Breakdown (December 2024)

Cell Impact AB net assets breakdown by equity component as of December 2024.

Component	Amount	Percentage
Common Stock	Skr80.60 Million	36.79%
Other Components	Skr734.73 Million	335.37%
Total Equity	Skr219.08 Million	100.00%

Cell Impact AB Competitors by Market Cap

The table below lists competitors of Cell Impact AB ranked by their market capitalization.

Company	Market Cap
MEMIONTEC HOLDINGS LTD F:8900	$669.97K
M.T.I Wireless Edge Ltd LSE:MWE	$671.44K
Lilium NV NASDAQ:LILM	$671.84K
Prostatype Genomics AB ST:PROGEN	$672.01K
SpectraCure AB ST:SPEC	$665.71K
IMAGE POWER S.A. ZY -10 F:7UQ	$665.70K
Infinitum Copper Corp V:INFI	$665.03K
Panthera Resources PLC LSE:PAT	$664.58K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Cell Impact AB's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 303,369,000 to 219,081,000, a change of -84,288,000 (-27.8%).
Net loss of 100,433,000 reduced equity.
New share issuances of 17,821,000 increased equity.
Other comprehensive income increased equity by 39,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Skr-100.43 Million	-45.84%
Share Issuances	Skr17.82 Million	+8.13%
Other Comprehensive Income	Skr39.00K	+0.02%
Other Changes	Skr-1.72 Million	-0.78%
Total Change	Skr-	-27.78%

Book Value vs Market Value Analysis

This analysis compares Cell Impact AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.06x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 0.50x to 0.06x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2008-12-31	Skr0.04	Skr0.02	x
2009-12-31	Skr0.04	Skr0.02	x
2010-12-31	Skr0.04	Skr0.02	x
2011-12-31	Skr0.22	Skr0.02	x
2012-12-31	Skr0.05	Skr0.02	x
2013-12-31	Skr1.88	Skr0.02	x
2014-12-31	Skr0.52	Skr0.02	x
2015-12-31	Skr0.27	Skr0.02	x
2016-12-31	Skr0.87	Skr0.02	x
2017-12-31	Skr0.33	Skr0.02	x
2018-12-31	Skr0.79	Skr0.02	x
2019-12-31	Skr1.26	Skr0.02	x
2020-12-31	Skr4.01	Skr0.02	x
2021-12-31	Skr0.76	Skr0.02	x
2022-12-31	Skr1.36	Skr0.02	x
2023-12-31	Skr2.77	Skr0.02	x
2024-12-31	Skr0.35	Skr0.02	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Cell Impact AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -45.84%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -269.08%
• Asset Turnover: 0.14x
• Equity Multiplier: 1.19x
Recent ROE (-45.84%) is above the historical average (-144.41%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2008	1.22%	0.00%	0.00x	1.04x	Skr-32.95K
2009	-0.03%	0.00%	0.00x	1.01x	Skr-37.66K
2010	-109.96%	-1612.21%	0.00x	42.91x	Skr-455.84K
2011	-770.57%	-834.79%	0.23x	4.08x	Skr-15.12 Million
2012	-482.38%	-605.90%	0.25x	3.17x	Skr-8.29 Million
2013	-47.24%	-228.79%	0.17x	1.20x	Skr-9.21 Million
2014	-94.25%	-219.33%	0.31x	1.37x	Skr-8.57 Million
2015	-315.52%	-397.31%	0.24x	3.28x	Skr-7.62 Million
2016	-20.74%	-470.10%	0.03x	1.27x	Skr-12.72 Million
2017	-79.23%	-1190.89%	0.05x	1.28x	Skr-20.60 Million
2018	-232.90%	-679.04%	0.17x	1.99x	Skr-46.49 Million
2019	-107.43%	-406.08%	0.21x	1.29x	Skr-52.91 Million
2020	-21.92%	-151.00%	0.12x	1.20x	Skr-64.45 Million
2021	-55.99%	-111.92%	0.30x	1.67x	Skr-94.12 Million
2022	-32.13%	-135.68%	0.19x	1.24x	Skr-136.65 Million
2023	-40.02%	-256.88%	0.12x	1.26x	Skr-151.74 Million
2024	-45.84%	-269.08%	0.14x	1.19x	Skr-122.34 Million

Industry Comparison

This section compares Cell Impact AB's net assets metrics with peer companies in the Metal Fabrication industry.

Industry Context

Industry: Metal Fabrication
Average net assets among peers: $154,129,800
Average return on equity (ROE) among peers: -14.05%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Cell Impact AB (CI)	Skr187.48 Million	1.22%	0.16x	$665.74K
AGES Industri AB (publ) (AGES-B)	$307.00 Million	-50.81%	1.77x	$23.99 Million
Nordic Flanges Group AB (NFGAB)	$79.66 Million	-20.54%	1.02x	$7.90 Million
Precomp Solutions AB Series B (PCOM-B)	$16.23 Million	-41.55%	5.59x	$2.58 Million
ProfilGruppen AB (publ) (PROF-B)	$324.60 Million	22.49%	1.29x	$88.38 Million
Troax Group AB (TROAX)	$43.16 Million	20.17%	2.16x	$976.35 Million

About Cell Impact AB

ST:CI Sweden Metal Fabrication

Market Cap

$665.74K

Skr6.19 Million SEK

Market Cap Rank

#30907 Global

#721 in Sweden

Share Price

Skr0.02

Change (1 day)

-4.55%

52-Week Range

Skr0.02 - Skr0.47

All Time High

Skr64.00